Advisory Alpha’s Sabra Healthcare REIT SBRA Stock Holding History

Advisory Alpha’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-287	Closed	-$3.37K	–	507
2020 Q1	$3.37K	Buy	+287	New	+$5.29K	﹤0.01%	544

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPC

Long Pond Capital New York $1.05B AUM 16.49% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Advisory Alpha's SBRA Position: Q2 2020 in Review

Advisory Alpha sold out of Sabra Healthcare REIT (SBRA) in Q2 2020, closing a stake of 287 shares — an estimated $3.37K sold.

Advisory Alpha first reported a position in SBRA in Q1 2020 and held it in 1 quarter. The position peaked at $3.37K in Q1 2020. 317 funds tracked by Wall St. Rank hold SBRA as of Q2 2020.

Advisory Alpha reported no remaining Sabra Healthcare REIT position as of Q2 2020 after selling out during the quarter.
Advisory Alpha sold 287 Sabra Healthcare REIT shares in Q2 2020, an estimated $3.37K.
Advisory Alpha first reported a position in Sabra Healthcare REIT in Q1 2020 and held it in 1 quarter.
Advisory Alpha's Sabra Healthcare REIT position peaked at $3.37K in Q1 2020.
317 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2020.

Based on Advisory Alpha's 13F filing for Q2 2020, filed 14 Aug 2020.